Human T helper cells specific for HIV reverse transcriptase: possible role in intrastructural help for HIV envelope-specific antibodies (Q71696201)

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:7539750%20AND%20SRC:MED&resulttype=core&format=json

20 October 2019

title

Human T helper cells specific for HIV reverse transcriptase: possible role in intrastructural help for HIV envelope-specific antibodies (English)

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:7539750%20AND%20SRC:MED&resulttype=core&format=json

20 October 2019

author name string

F Manca

1

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:7539750%20AND%20SRC:MED&resulttype=core&format=json

20 October 2019

D Fenoglio

2

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:7539750%20AND%20SRC:MED&resulttype=core&format=json

20 October 2019

M T Valle

3

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:7539750%20AND%20SRC:MED&resulttype=core&format=json

20 October 2019

G Li Pira

4

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:7539750%20AND%20SRC:MED&resulttype=core&format=json

20 October 2019

A Kunkl

5

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:7539750%20AND%20SRC:MED&resulttype=core&format=json

20 October 2019

R S Balderas

6

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:7539750%20AND%20SRC:MED&resulttype=core&format=json

20 October 2019

R G Baccala

7

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:7539750%20AND%20SRC:MED&resulttype=core&format=json

20 October 2019

D H Kono

8

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:7539750%20AND%20SRC:MED&resulttype=core&format=json

20 October 2019

A Ferraris

9

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:7539750%20AND%20SRC:MED&resulttype=core&format=json

20 October 2019

D Saverino

10

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:7539750%20AND%20SRC:MED&resulttype=core&format=json

20 October 2019

publication date

1 May 1995

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:7539750%20AND%20SRC:MED&resulttype=core&format=json

European Journal of Immunology

20 October 2019

published in

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:7539750%20AND%20SRC:MED&resulttype=core&format=json

20 October 2019

volume

25

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:7539750%20AND%20SRC:MED&resulttype=core&format=json

20 October 2019

issue

5

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:7539750%20AND%20SRC:MED&resulttype=core&format=json

20 October 2019

page(s)

1217-1223

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:7539750%20AND%20SRC:MED&resulttype=core&format=json

Polyreactivity increases the apparent affinity of anti-HIV antibodies by heteroligation

20 October 2019

cites work

1 reference

12 December 2020

Very few substitutions in a germ line antibody are required to initiate significant domain exchange.

1 reference

12 December 2020

Role of immune mechanisms in induction of HIV-1 broadly neutralizing antibodies

1 reference

12 December 2020

Rational design of envelope identifies broadly neutralizing human monoclonal antibodies to HIV-1

1 reference

12 December 2020

Rescue of HIV-1 broad neutralizing antibody-expressing B cells in 2F5 VH x VL knockin mice reveals multiple tolerance controls

1 reference

12 December 2020

Focused Evolution of HIV-1 Neutralizing Antibodies Revealed by Structures and Deep Sequencing

1 reference

12 December 2020

Broad neutralization coverage of HIV by multiple highly potent antibodies

1 reference

12 December 2020

Differential reactivity of germ line allelic variants of a broadly neutralizing HIV-1 antibody to a gp41 fusion intermediate conformation

1 reference

12 December 2020

Computation-guided backbone grafting of a discontinuous motif onto a protein scaffold

1 reference

12 December 2020

Prospects for an HIV vaccine: leading B cells down the right path

1 reference

12 December 2020

Structure of HIV-1 gp120 V1/V2 domain with broadly neutralizing antibody PG9

1 reference

12 December 2020

Rational design of vaccines to elicit broadly neutralizing antibodies to HIV-1.

1 reference

12 December 2020

Neutralizing antibodies and control of HIV: moves and countermoves.

1 reference

12 December 2020

Biochemically defined HIV-1 envelope glycoprotein variant immunogens display differential binding and neutralizing specificities to the CD4-binding site

1 reference

12 December 2020

Timing of the components of the HIV life cycle in productively infected CD4+ T cells in a population of HIV-infected individuals.

1 reference

12 December 2020

Sequence and Structural Convergence of Broad and Potent HIV Antibodies That Mimic CD4 Binding

1 reference

12 December 2020

Human neutralizing monoclonal antibodies of the IgG1 subtype protect against mucosal simian-human immunodeficiency virus infection

1 reference

12 December 2020

Protection of macaques against vaginal transmission of a pathogenic HIV-1/SIV chimeric virus by passive infusion of neutralizing antibodies

1 reference

12 December 2020

Immune inhibitory receptors

1 reference

12 December 2020

Improved elicitation of neutralizing antibodies against primary human immunodeficiency viruses by soluble stabilized envelope glycoprotein trimers

1 reference

12 December 2020

Antibody protects macaques against vaginal challenge with a pathogenic R5 simian/human immunodeficiency virus at serum levels giving complete neutralization in vitro

1 reference

12 December 2020

Crystal structure of a neutralizing human IGG against HIV-1: a template for vaccine design

1 reference

12 December 2020

Broadly neutralizing antibodies targeted to the membrane-proximal external region of human immunodeficiency virus type 1 glycoprotein gp41.

1 reference

12 December 2020

Visualization of the intracellular behavior of HIV in living cells

1 reference

12 December 2020

Antibody domain exchange is an immunological solution to carbohydrate cluster recognition

1 reference

12 December 2020

Characterization of molecular features, antigen-binding, and in vitro properties of IgG and IgM variants of 4E10, an anti-HIV type 1 neutralizing monoclonal antibody.

1 reference

12 December 2020

Molecular determinants of immunogenicity: the immunon model of immune response

1 reference

12 December 2020

Clonal deletion of B lymphocytes in a transgenic mouse bearing anti-MHC class I antibody genes

1 reference

12 December 2020

Effects of changes in gp120-CD4 binding affinity on human immunodeficiency virus type 1 envelope glycoprotein function and soluble CD4 sensitivity

1 reference

12 December 2020

Molecular profile of an antibody response to HIV-1 as probed by combinatorial libraries

1 reference

12 December 2020

Efficient neutralization of primary isolates of HIV-1 by a recombinant human monoclonal antibody

1 reference

12 December 2020

Multivalent, but not divalent, antigen receptor cross-linkers synergize with CD40 ligand for induction of Ig synthesis and class switching in normal murine B cells. A redefinition of the TI-2 vs T cell-dependent antigen dichotomy

1 reference

12 December 2020

Protection against HIV-1 infection in hu-PBL-SCID mice by passive immunization with a neutralizing human monoclonal antibody against the gp120 CD4-binding site.

1 reference

12 December 2020

Human monoclonal antibody 2G12 defines a distinctive neutralization epitope on the gp120 glycoprotein of human immunodeficiency virus type 1

1 reference

12 December 2020

The consequence of passive administration of an anti-human immunodeficiency virus type 1 neutralizing monoclonal antibody before challenge of chimpanzees with a primary virus isolate

1 reference

12 December 2020

Recombinant human monoclonal antibody IgG1b12 neutralizes diverse human immunodeficiency virus type 1 primary isolates

1 reference

12 December 2020

Passive immunization with a human monoclonal antibody protects hu-PBL-SCID mice against challenge by primary isolates of HIV-1.

1 reference

12 December 2020

Antigens varying in affinity for the B cell receptor induce differential B lymphocyte responses.

1 reference

12 December 2020

Protection of Macaques against pathogenic simian/human immunodeficiency virus 89.6PD by passive transfer of neutralizing antibodies.

1 reference

12 December 2020

The cytoplasmic tail slows the folding of human immunodeficiency virus type 1 Env from a late prebundle configuration into the six-helix bundle

1 reference

12 December 2020

Broadly neutralizing anti-HIV antibody 4E10 recognizes a helical conformation of a highly conserved fusion-associated motif in gp41

1 reference

12 December 2020

Cardiolipin polyspecific autoreactivity in two broadly neutralizing HIV-1 antibodies.

1 reference

12 December 2020

Human immunodeficiency virus type 1 env clones from acute and early subtype B infections for standardized assessments of vaccine-elicited neutralizing antibodies

1 reference

12 December 2020

Characterization of antibody responses elicited by human immunodeficiency virus type 1 primary isolate trimeric and monomeric envelope glycoproteins in selected adjuvants

1 reference

12 December 2020

Distribution and three-dimensional structure of AIDS virus envelope spikes

1 reference

12 December 2020

In vivo and in vitro escape from neutralizing antibodies 2G12, 2F5, and 4E10.

1 reference

12 December 2020

Fc receptor but not complement binding is important in antibody protection against HIV.

1 reference

12 December 2020

Production and titration of lentiviral vectors

1 reference

12 December 2020

Broadly neutralizing human anti-HIV antibody 2G12 is effective in protection against mucosal SHIV challenge even at low serum neutralizing titers

1 reference

12 December 2020

Effective, low-titer antibody protection against low-dose repeated mucosal SHIV challenge in macaques

1 reference

12 December 2020

Broad and potent neutralizing antibodies from an African donor reveal a new HIV-1 vaccine target

1 reference

12 December 2020

Germline-like predecessors of broadly neutralizing antibodies lack measurable binding to HIV-1 envelope glycoproteins: implications for evasion of immune responses and design of vaccine immunogens

1 reference

12 December 2020

Decoration of T-independent antigen with ligands for CD22 and Siglec-G can suppress immunity and induce B cell tolerance in vivo

1 reference

12 December 2020

The role of antibodies in HIV vaccines

1 reference

12 December 2020

Rational antibody-based HIV-1 vaccine design: current approaches and future directions

1 reference

12 December 2020

Structure and function of broadly reactive antibody PG16 reveal an H3 subdomain that mediates potent neutralization of HIV-1

1 reference

12 December 2020

Crystal Structure of PG16 and Chimeric Dissection with Somatically Related PG9: Structure-Function Analysis of Two Quaternary-Specific Antibodies That Effectively Neutralize HIV-1

1 reference

12 December 2020

Structural Basis for Broad and Potent Neutralization of HIV-1 by Antibody VRC01

1 reference

12 December 2020

Effects of anti-gp120 monoclonal antibodies on CD4 receptor binding by the env protein of human immunodeficiency virus type 1

1 reference

https://api.crossref.org/works/10.1002%2FEJI.1830250513

7 January 2021

Functional analysis of influenza-specific helper T cell clones in vivo. T cells specific for internal viral proteins provide cognate help for B cell responses to hemagglutinin

1 reference

https://api.crossref.org/works/10.1002%2FEJI.1830250513

7 January 2021

Antibody production to the nucleocapsid and envelope of the hepatitis B virus primed by a single synthetic T cell site

1 reference

https://api.crossref.org/works/10.1002%2FEJI.1830250513

7 January 2021

Induction of protective immunity against rabies by immunization with rabies virus ribonucleoprotein

1 reference

https://api.crossref.org/works/10.1002%2FEJI.1830250513

7 January 2021

Standardized and simplified nomenclature for proteins common to all retroviruses

1 reference

https://api.crossref.org/works/10.1002%2FEJI.1830250513

7 January 2021

Diagnosis of AIDS by using a 12-amino acid peptide representing an immunodominant epitope of the human immunodeficiency virus

1 reference

https://api.crossref.org/works/10.1002%2FEJI.1830250513

7 January 2021

Human immunodeficiency virus reverse transcriptase T helper epitopes identified in mice and humans: correlation with a cytotoxic T cell epitope.

1 reference

https://api.crossref.org/works/10.1002%2FEJI.1830250513

7 January 2021

An epitope in human immunodeficiency virus 1 reverse transcriptase recognized by both mouse and human cytotoxic T lymphocytes.

1 reference

https://api.crossref.org/works/10.1002%2FEJI.1830250513

7 January 2021

Long-term culture and fine specificity of human cytotoxic T-lymphocyte clones reactive with human immunodeficiency virus type 1.

1 reference

https://api.crossref.org/works/10.1002%2FEJI.1830250513

7 January 2021

HIV-1 reverse transcriptase is a target for cytotoxic T lymphocytes in infected individuals

1 reference

https://api.crossref.org/works/10.1002%2FEJI.1830250513

7 January 2021

TH1 and TH2 cells: different patterns of lymphokine secretion lead to different functional properties

1 reference

https://api.crossref.org/works/10.1002%2FEJI.1830250513

7 January 2021

Collaboration of helper and cytotoxic T lymphocytes

1 reference

https://api.crossref.org/works/10.1002%2FEJI.1830250513

7 January 2021

Roles of alpha beta and gamma delta T cell subsets in viral immunity

1 reference

https://api.crossref.org/works/10.1002%2FEJI.1830250513

7 January 2021

Role of flanking variable sequences in antigenicity of consensus regions of HIV gp120 for recognition by specific human T helper clones

1 reference

https://api.crossref.org/works/10.1002%2FEJI.1830250513

7 January 2021

Identification of a major human immunodeficiency virus-1 reverse transcriptase epitope recognized by mouse CD4+ T lymphocytes

1 reference

https://api.crossref.org/works/10.1002%2FEJI.1830250513

7 January 2021

Epitope mapping of two immunodominant domains of gp41, the transmembrane protein of human immunodeficiency virus type 1, using ten human monoclonal antibodies

1 reference

https://api.crossref.org/works/10.1002%2FEJI.1830250513

7 January 2021

Inhibitory activity of HIV envelope gp120 dominates over its antigenicity for human T cells

1 reference

https://api.crossref.org/works/10.1002%2FEJI.1830250513

7 January 2021

Genomically imposed and somatically modified human thymocyte V beta gene repertoires

1 reference

https://api.crossref.org/works/10.1002%2FEJI.1830250513

7 January 2021

Receptor-mediated antigen uptake and its effect on antigen presentation to class II-restricted T lymphocytes

1 reference

https://api.crossref.org/works/10.1002%2FEJI.1830250513

7 January 2021

Factors underlying spontaneous inactivation and susceptibility to neutralization of human immunodeficiency virus

1 reference

https://api.crossref.org/works/10.1002%2FEJI.1830250513

7 January 2021

Human immunodeficiency virus-1 reverse transcriptase immunodominant CD4+ T cell epitopes: a peptide-based multiparametric assessment in the mouse.

1 reference

https://api.crossref.org/works/10.1002%2FEJI.1830250513

7 January 2021

Introduction of soluble protein into the class I pathway of antigen processing and presentation

1 reference

https://api.crossref.org/works/10.1002%2FEJI.1830250513

7 January 2021

Human T cell response to the surface antigen of hepatitis B virus (HBsAg). Endosomal and nonendosomal processing pathways are accessible to both endogenous and exogenous antigen

1 reference

https://api.crossref.org/works/10.1002%2FEJI.1830250513

7 January 2021

Class II major histocompatibility complex-restricted T cells specific for a virion structural protein that do not recognize exogenous influenza virus. Evidence that presentation of labile T cell determinants is favored by endogenous antigen synthesi

1 reference

https://api.crossref.org/works/10.1002%2FEJI.1830250513

7 January 2021

An endogenous processing pathway in vaccinia virus-infected cells for presentation of cytoplasmic antigens to class II-restricted T cells

1 reference

https://api.crossref.org/works/10.1002%2FEJI.1830250513

7 January 2021

Anchor sequence-dependent endogenous processing of human immunodeficiency virus 1 envelope glycoprotein gp160 for CD4+ T cell recognition

1 reference

https://api.crossref.org/works/10.1002%2FEJI.1830250513

7 January 2021

The carrier effect in the secondary response to hapten-protein conjugates. II. Cellular cooperation.

1 reference

https://api.crossref.org/works/10.1002%2FEJI.1830250513

7 January 2021

An influenza virus matrix protein-specific human T cell line with helper activity forin vitro anti-hemagglutinin antibody production

1 reference

https://api.crossref.org/works/10.1002%2FEJI.1830250513

7 January 2021

B cells on the podium: regulatory roles of surface and secreted immunoglobulins

1 reference

https://api.crossref.org/works/10.1002%2FEJI.1830250513

7 January 2021

Effect of antigen/antibody ratio on macrophage uptake, processing, and presentation to T cells of antigen complexed with polyclonal antibodies

1 reference

https://api.crossref.org/works/10.1002%2FEJI.1830250513

7 January 2021

Rapid development of isolate-specific neutralizing antibodies after primary HIV-1 infection and consequent emergence of virus variants which resist neutralization by autologous sera.

1 reference

https://api.crossref.org/works/10.1002%2FEJI.1830250513

7 January 2021

Human immunodeficiency virus genetic variation that can escape cytotoxic T cell recognition

1 reference

https://api.crossref.org/works/10.1002%2FEJI.1830250513

7 January 2021

Non-covalent complexes of HIV gp120 with CD4 and/or mAbs enhance activation of gp120-specific T clones and provide intermolecular help for anti-CD4 antibody production

1 reference

https://api.crossref.org/works/10.1002%2FEJI.1830250513

7 January 2021

Preferential V beta gene usage and lack of junctional sequence conservation among human T cell receptors specific for a tetanus toxin-derived peptide: evidence for a dominant role of a germline-encoded V region in antigen/major histocompatibility co

1 reference

https://api.crossref.org/works/10.1002%2FEJI.1830250513

7 January 2021

Isolation of lysozyme-specific T cell clones that discriminate between native and denatured antigen

1 reference

https://api.crossref.org/works/10.1002%2FEJI.1830250513

7 January 2021

Identifiers

DOI

10.1002/EJI.1830250513

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:7539750%20AND%20SRC:MED&resulttype=core&format=json

20 October 2019

1 reference